References
- Alexander C.M., Werb Z. Proteinases and extracellular matrix remodelling. Current Opinion in Cell Biology 1989; 1: 974–982
- Bashkin P., Doctrov S., Klagsbrun M., Svahn C.M., Folkman J., Vlodavsky I. Basic fibroblast growth factor binds to sub-endothelial extracellular matrix and is released by heparinatase or heparin like molecules. Biochemistry 1989; 28: 1737–1743
- Brem S., Pries I., Langer R., Brem H., Folkman J., Patz A. Inhibition of neovascularisation by an extract derived from vitreous. American Journal of Ophthalmology 1977; 84: 323–328
- Cawston T.E., Curry V.A., Clark I.M., Hazleman B.L. Identification of a new metalloproteinase inhibitor that forms tight binding complex with collagenase. Biochemical Journal 1990; 269: 183–187
- Edwards D.J., Murphy G., Reynolds J.J., Whitman S.E., Docherty A.J.P., Angel P., Heath J. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO Journal 1987; 6: 1899–1904
- Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., Vlodavsky I. A heparin binding angiogenic protein—basic fibroblast growth factor—is stored within the extracellular matrix. American Journal of Pathology 1988; 130: 393–400
- Gospodarowicz D., Cheng J., Lui G., Baird A., Bohlen P. Isolation of brain fibroblast growth factor by heparin-sepharose affinity chromatography: identity with pituitary fibrblast growth factor. Proceedings of the National Academy of Sciences, USA 1984; 81: 6963–6971
- Hembury R.M., Ehrlich H.P. Immunolocalisation of collagenase and tissue inhibitor of metalloproteinases (TIMP) in hypertrophic scar tissue. British Journal of Dermatology 1986; 115: 409–420
- Huang J.S., Huang S.S., Kuo M.D. Bovine brain derived growth factor. Journal of Biological Chemistry 1986; 261: 11600–11608
- Kuettner K.E., Hiti J., Eisenstein R., Harper E. Collagenase inhibition by cationic proteins derided from cartilage and aorta. Biochemical and Biophysical Research Communications 1976; 72: 42–46
- Liotta L.A., Tryggvason K., Garbisa S., Gehron-Robey P., Abe S. Partila purification and characterisation of a neutral protease which cleaves type IV collagen. Biochemistry 1981; 20: 100–104
- Mignatti P., Tsuboi R., Robbins E., Rifkin D.B. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor induced proteinases. Journal of Cell Biology 1989; 108: 671–682
- Odedra R., Weiss J.B. A synergistic effect on microvessel endothelial cell proliferation between basic fibroblast growth factor and endothelial cell stimulating angiogenesis factor. Biochemical and Biophysical Research Communications 1987; 143: 947–952
- Raymond L., Jacobson B. Isolation and identification of stimulatory and inhibitory cell growth factors in bovine vitreous. Experimental Eye Research 1982; 34: 267–286
- Shipley G.D., Tucker R.F., Moses H.L. Type β-transforming growth factor. Proceedings of the National Academy of Sciences, USA 1985; 82: 4147–4151
- Taylor C.M., Weiss J.B. Partial purification of a 5·7K glycoprotein from bovine vitreous which inhibits both angiogenesis and collagenase activity. Biochemical and Biophysical Research Communications 1985; 133: 911–916
- Taylor C.M., Kissun R.D., Schor A.M., McLeod D., Garner A., Weiss J.B. Endothelial cell stimulating angiogenesis factor in vitreous from extraretinal neovascularisations. Investigative Ophthalmology and Visual Science 1989; 30: 2174–2178
- Weiss J.B., Hill C.R., Davis R.J., McLaughlin B., Sedowfia K.A., Brown R.A. Activation of a procollagenase by a low-molecular-weight angiogenesis factor. Bioscience Reports 1983; 3: 171–177
- Weiss J.B., Odedra R., McLaughlin B. Low molecular mass angiogenic factors: their role in angiogenesis. Microcirculation: an Update, M. Tsuchiya. Elsevier, Holland 1987; 2: 777–780
- Vlodavsky I., Michaeli R.I., Bar-Ner M., Fridman R., Horowitz A.T., Fuks Z., Biran S. Involvement of heparanase in tumour metastasis and angiogenesis. Israel Journal of Medical Science 1988; 24: 464–470